LOTUSEYE vs RAINBOW: Stock Comparison

Lotus Eye Hospital and Institute Limited vs Rainbow Childrens Medicare Limited

Live data: 6 August 2026, 4:08 PM IST • Source: NSE and company filings

Rainbow Childrens Medicare Limited is the larger company by market capitalisation. Lotus Eye Hospital and Institute Limited shows lower leverage, while Rainbow Childrens Medicare Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Lotus Eye Hospital and Institute Limited and Rainbow Childrens Medicare Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, LOTUSEYE is more favourable on 2 of 13 scored metrics and RAINBOW on 11These counts are context-free and are not an overall rating.

Key Differences

Market Cap
RAINBOW is the larger company
₹15,965 Cr vs ₹246 Cr
P/E Ratio
RAINBOW has a lower P/E
56.76x vs 2,925x
P/B Ratio
LOTUSEYE has a lower P/B
4.05x vs 9.83x
EPS
RAINBOW has higher earnings per share
₹27.48 vs ₹0.04
Dividend Yield
RAINBOW has a higher dividend yield
0.2% vs 0%
Revenue Growth (TTM YoY)
RAINBOW has faster revenue growth
24.3% vs 18.2%
EPS Growth (TTM YoY)
RAINBOW has faster EPS growth
39.1% vs 0%
Qtr Sales Growth
RAINBOW has stronger quarterly sales growth
24.3% vs 18.2%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricLOTUSEYERAINBOW
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricLOTUSEYERAINBOW
Live Price₹117.24₹1,573.2
Day Change-0.5%-1.59%
Volume2,4601.01 L
52-Week High₹147₹1,610
52-Week Low₹70.84₹1,084
Distance from 52W High-20.24%-2.29%

Valuation

MetricLOTUSEYERAINBOW
Market Cap₹246 Cr₹15,965 Cr
P/E Ratio2,925x56.76x
P/B Ratio4.05x9.83x
EPS₹0.04₹27.48
Book Value₹28.23₹162.36
Dividend Yield0%0.2%

Growth

MetricLOTUSEYERAINBOW
Revenue Growth (TTM YoY)18.2%24.3%
EPS Growth (TTM YoY)0%39.1%
Qtr Sales Growth18.2%24.3%
Qtr Profit Growth-224%38.6%

Profitability & Leverage

MetricLOTUSEYERAINBOW
ROE0.13%15.9%
ROCE1.16%17.4%
Net Margin0.15%16.34%
Operating Margin6.29%32.2%
Debt to Equity0.26x0.54x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricLOTUSEYERAINBOW
Promoter Holding37.39%49.84%
FII Holding0%16.03% 1.21 pp
DII Holding0.02%22.56% 1.43 pp
Public Holding59.85% 0.01 pp11.39% 0.28 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Lotus Eye Hospital and Institute Limited and Rainbow Childrens Medicare Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.